JP5965927B2 - デコリン組成物およびその使用 - Google Patents

デコリン組成物およびその使用 Download PDF

Info

Publication number
JP5965927B2
JP5965927B2 JP2013558110A JP2013558110A JP5965927B2 JP 5965927 B2 JP5965927 B2 JP 5965927B2 JP 2013558110 A JP2013558110 A JP 2013558110A JP 2013558110 A JP2013558110 A JP 2013558110A JP 5965927 B2 JP5965927 B2 JP 5965927B2
Authority
JP
Japan
Prior art keywords
decorin
medium
core protein
cell
gag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013558110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518508A (ja
JP2014518508A5 (enExample
Inventor
トーマス ブレック，グレゴリー
トーマス ブレック，グレゴリー
ジョン コリンズ，イアン
ジョン コリンズ，イアン
ジョセフ フライ，マーク
ジョセフ フライ，マーク
Original Assignee
キャタレント ファーマ ソリューションズ リミテッド ライアビリティ カンパニー
キャタレント ファーマ ソリューションズ リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キャタレント ファーマ ソリューションズ リミテッド ライアビリティ カンパニー, キャタレント ファーマ ソリューションズ リミテッド ライアビリティ カンパニー filed Critical キャタレント ファーマ ソリューションズ リミテッド ライアビリティ カンパニー
Publication of JP2014518508A publication Critical patent/JP2014518508A/ja
Publication of JP2014518508A5 publication Critical patent/JP2014518508A5/ja
Application granted granted Critical
Publication of JP5965927B2 publication Critical patent/JP5965927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2013558110A 2011-03-14 2012-03-13 デコリン組成物およびその使用 Active JP5965927B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161452299P 2011-03-14 2011-03-14
US61/452,299 2011-03-14
PCT/US2012/028911 WO2012125626A2 (en) 2011-03-14 2012-03-13 Decorin compositions and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016082308A Division JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2014518508A JP2014518508A (ja) 2014-07-31
JP2014518508A5 JP2014518508A5 (enExample) 2014-09-11
JP5965927B2 true JP5965927B2 (ja) 2016-08-10

Family

ID=46828968

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013558110A Active JP5965927B2 (ja) 2011-03-14 2012-03-13 デコリン組成物およびその使用
JP2016082308A Pending JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用
JP2018146607A Active JP6831813B2 (ja) 2011-03-14 2018-08-03 デコリン組成物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016082308A Pending JP2016185952A (ja) 2011-03-14 2016-04-15 デコリン組成物およびその使用
JP2018146607A Active JP6831813B2 (ja) 2011-03-14 2018-08-03 デコリン組成物およびその使用

Country Status (6)

Country Link
US (2) US20120238727A1 (enExample)
EP (2) EP3456837A3 (enExample)
JP (3) JP5965927B2 (enExample)
CN (1) CN103917655B (enExample)
DK (1) DK2686335T3 (enExample)
WO (1) WO2012125626A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2989208A4 (en) * 2013-04-22 2016-12-07 Catalent Pharma Solutions Llc DECORINAL COMPOSITIONS FOR VETERINARY MEDICINE AND USE THEREOF
AU2014265632B2 (en) 2013-05-14 2019-09-19 Medimmune, Llc Synthetic oligosaccharide subunits of the psl exopolysaccharide of pseudomonas aeruginosa and uses thereof
JP2018048053A (ja) 2016-09-23 2018-03-29 昭和電工株式会社 ＳｉＣ単結晶成長用坩堝
AU2019299110B2 (en) * 2018-07-03 2025-07-17 Catalent Pharma Solutions, Llc Multifunctional protein molecules comprising decorin and use thereof
EP4114428A4 (en) * 2020-03-05 2025-03-12 Diamedica USA Inc. ULINASTATIN POLYPEPTIDES

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI906411A7 (fi) * 1988-06-28 1990-12-27 La Jolla Cancer Res Foundation Solujen lisääntymisen esto Decorinilla
US6509314B1 (en) * 1988-06-28 2003-01-21 The Burnham Institute Methods of preventing or reducing scarring with decorin or biglycan
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
CA2123418A1 (en) * 1991-11-14 1993-05-27 Erkki I. Ruoslahti Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
EP0636175A1 (en) * 1992-04-03 1995-02-01 La Jolla Cancer Research Foundation Decorin fragments and methods of inhibiting cell regulatory factors
US5567807A (en) * 1994-07-08 1996-10-22 La Jolla Cancer Research Foundation Processes for the purification of human recombinant decorin and the detection of guanidinium ions
CN1431911A (zh) * 2000-05-05 2003-07-23 Gtc生物治疗学公司 转基因产生的核心蛋白聚糖
AU2001271614B2 (en) 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
US20040235173A1 (en) 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
US20030224415A1 (en) 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
US20030124152A1 (en) * 2001-11-02 2003-07-03 Pang Danny Zhong Der Use of decorin in a cosmetic or dermatologic composition
KR100495126B1 (ko) * 2002-04-16 2005-06-14 한국생명공학연구원 Ｎ-아세틸갈락토스아미닐트랜스퍼라제 활성을 갖는 융합 단백질, 이를 코딩하는 유전자 및 상기 유전자가 도입된 형질전환 세포주
TWI461434B (zh) * 2007-03-23 2014-11-21 Asahi Kasei Pharma Corp Preparation of high purity soluble thrombin modulators
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

Also Published As

Publication number Publication date
JP2016185952A (ja) 2016-10-27
WO2012125626A3 (en) 2014-04-24
CN103917655B (zh) 2016-05-25
JP2014518508A (ja) 2014-07-31
DK2686335T3 (en) 2018-07-30
JP2018191647A (ja) 2018-12-06
JP6831813B2 (ja) 2021-02-17
US20120238727A1 (en) 2012-09-20
CN103917655A (zh) 2014-07-09
EP2686335A4 (en) 2015-11-25
US20220073579A1 (en) 2022-03-10
EP3456837A3 (en) 2019-04-24
WO2012125626A2 (en) 2012-09-20
EP3456837A2 (en) 2019-03-20
EP2686335A2 (en) 2014-01-22
EP2686335B1 (en) 2018-04-25

Similar Documents

Publication Publication Date Title
JP6831813B2 (ja) デコリン組成物およびその使用
US5723318A (en) DNA coding for megakaryocyte potentiator
CN116574172B (zh) 重组人源化i型胶原蛋白及其制备方法
CN1143386A (zh) 转化生长因子α-H1
EP2516464B1 (en) Recombinant factor h and variants and conjugates thereof
ES2686968T3 (es) Proteínas de fusión bifuncionales para inhibir la angiogénesis en el microambiente tumoral y para activar las respuestas inmunitarias adaptativas y los genes y usos de las mismas
JP2010187691A (ja) 哺乳類のトランスフォーミング増殖因子β−９
EP0374044B1 (en) TGF - beta 1 / beta 2 : a novel chimeric transforming growth factor-beta.
JP2010213699A (ja) 組換えヒトエリスロポイエチンを発現する宿主細胞
JPH06217778A (ja) ヒトｍｋ遺伝子及び蛋白質の配列
SK43097A3 (en) Method for purifying keratinocyte growth factors
US6008328A (en) Method for purifying keratinocyte growth factors
CA2216165C (en) Ndf peptides
HK40004571A (en) Decorin compositions and use thereof
CN106337043B (zh) 高稳定性的人胰蛋白酶突变体
CN110577954A (zh) 突变的肝细胞生长因子基因及其应用
US20030119108A1 (en) Method of making FGF-12 and KGF-2
JP3490125B2 (ja) 巨核球増幅因子をコードする遺伝子
CN120554493A (zh) 一种改善皮肤弹性的弹性蛋白肽及其制备方法
Ji-Dong et al. Expression of Recombinant Human BMP-6 in CHO Cell by Fusion of a BMP-6 Mature Peptide to the Signal Peptide and Propeptide of Another Homologue Protein
CN117529496A (zh) 小分子调控的细胞信号传导表达系统
JPH0656895A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、およびそのベクターで形質転換された宿主細胞
JPH1189582A (ja) 炎症性サイトカイン誘導因子の遺伝子
CN113735979A (zh) 一种重组人血小板衍生因子（rhPDGF-BB）-Fc融合蛋白及其使用
WO2001074852A2 (en) Protein having activity as an angiogenesis modulator

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160415

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20160415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160418

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160602

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160621

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160704

R150 Certificate of patent or registration of utility model

Ref document number: 5965927

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250